<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title> Inovio Pharmaceuticals</title>
<link>http://ir.inovio.com/</link>
<description></description>
<item>
<title>Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial</title>
<link>http://ir.inovio.com/2012-05-16-Inovio-Pharmaceuticals-Universal-Avian-Flu-Vaccine-Generates-Protective-Antibody-Responses-Against-Six-H5N1-Viruses-in-Phase-I-Trial</link>
<description>Inovio Synthetic DNA Vaccine Achieves Proof of Principle With Robust Antibody and T Cell Responses Against Diverse H5N1 Influenza Strains</description>
<pubDate>Wed, 16 May 2012 04:00:00 -0400</pubDate>
<guid>http://ir.inovio.com/2012-05-16-Inovio-Pharmaceuticals-Universal-Avian-Flu-Vaccine-Generates-Protective-Antibody-Responses-Against-Six-H5N1-Viruses-in-Phase-I-Trial</guid>
</item>
<item>
<title>Inovio Pharmaceuticals to Present at SPI 2012</title>
<link>http://ir.inovio.com/2012-05-15-Inovio-Pharmaceuticals-to-Present-at-SPI-2012</link>
<description></description>
<pubDate>Tue, 15 May 2012 04:00:00 -0400</pubDate>
<guid>http://ir.inovio.com/2012-05-15-Inovio-Pharmaceuticals-to-Present-at-SPI-2012</guid>
</item>
<item>
<title>Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results</title>
<link>http://ir.inovio.com/index.php?s=43&amp;item=478</link>
<description></description>
<pubDate>Wed, 09 May 2012 18:46:22 -0400</pubDate>
<guid>http://ir.inovio.com/index.php?s=43&amp;item=478</guid>
</item>
<item>
<title>Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer</title>
<link>http://ir.inovio.com/index.php?s=43&amp;item=477</link>
<description>Cancer Vaccine in Phase II Clinical Study</description>
<pubDate>Tue, 01 May 2012 04:00:00 -0400</pubDate>
<guid>http://ir.inovio.com/index.php?s=43&amp;item=477</guid>
</item>
<item>
<title>Inovio Pharmaceuticals Receives Defense Department Funding for Bioterrorism-Related Synthetic Vaccine Program</title>
<link>http://ir.inovio.com/index.php?s=43&amp;item=476</link>
<description>Second DOD grant extends development and testing of novel surface electroporation delivery device for synthetic DNA vaccines</description>
<pubDate>Mon, 02 Apr 2012 04:00:00 -0400</pubDate>
<guid>http://ir.inovio.com/index.php?s=43&amp;item=476</guid>
</item>
</channel>
</rss>

